Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 9—September 2006

Human Bocavirus Infection among Children, Jordan

Article Metrics
citations of this article
EID Journal Metrics on Scopus
Nasser M. Kaplan*†, Winifred Dove*, Ahmad F. Abu-Zeid†, Hiyam E. Shamoon†, Sawsan A. Abd-Eldayem†, and C. Anthony Hart*Comments to Author 
Author affiliations: *University of Liverpool, Liverpool, United Kingdom; †King Hussein Medical Centre, Amman, Jordan

Cite This Article


Human bocavirus was detected in 57 (18.3%) of 312 children with acute respiratory infection (ARI) who required hospitalization in Jordan. It was also detected in 30 (21.7%) of 138 children with severe ARI, in 27 (15.5%) of 174 with mild or moderate disease, and in 41 (72%) of 57 with other pathogens.

Acute respiratory infection (ARI) is a major cause of illness and death worldwide (1). Although ARI is the third most common cause of death overall, in children it is the major cause of death outside the neonatal period; an estimated 2 million deaths occur in children <5 years of age, predominantly in developing countries (2). Viruses are a cause of upper and lower respiratory tract infections in children and several of them have been described. Among these, respiratory syncytial virus (RSV) is most important, both in terms of prevalence and effect (3). However, in recent years, several new viruses have emerged. These include human metapneumovirus (4), severe acute respiratory syndrome coronavirus (5) and human coronaviruses HKU1 and NL63 (6,7).

In 2005, Allander et al. reported detection of a new human parvovirus that they named human bocavirus (HBoV) (8). They detected this virus by constructing libraries of amplified DNA and RNA from supernatants of nasopharyngeal aspirates of children with ARI and removing nonviral nucleic acids by ultracentrifugation, microfiltration, and treatment with DNase. From this analysis, a novel parvovirus sequence was obtained. The complete genome sequence was determined and HBoV was characterized. The only other related bocaviruses are bovine parvovirus and canine parvovirus 1 (CPV-1). A PCR detection method was devised that targeted the noncapsid protein-1 (NP-1) gene, and virus was detected in 24 (3%) of 806 children with ARI in Sweden. We used the same PCR detection method to determine whether HBoV is a potential cause of ARI in children in Jordan.

The Study

From December 2003 to May 2004, all children <5 years of age admitted to the pediatric wards of King Hussein Medical Centre (KHMC) and Queen Alia Hospital (QAH) in Amman, Jordan, were enrolled into the study after informed consent was obtained from parents or guardians. The study, which determined the etiology, inflammatory responses, and clinical effects of ARI was approved by the research ethical approval committee of the Royal Medical Services, Amman, Jordan. KHMC and QAH provide all hospital pediatric care for Amman and its surroundings.

Diagnosis of ARI and assessment of its severity was made by using World Health Organization (WHO) standard protocol for ARI based on the presence of cough, tachypnea, chest indrawing, and wheezing for <7 days (9). Severe disease was defined in children with a respiratory rate >60/minute and chest indrawing. Oxygen saturation (pO2) was measured by using pulse oximetry (Nellor, Puritan Bennet, UK), and a pO2 <85% was used as the cutoff for giving supplementary oxygen. Nasopharyngeal aspirates (NPAs) were collected by instilling 1 mL sterile phosphate-buffered saline through a nasopharyngeal mucous extractor. The aspirate was frozen at –80°C and transported frozen to Liverpool for analysis.

DNA and RNA were extracted from aspirates by using commercial kits (Qiagen, Basingstoke, UK). PCR or reverse transcription PCR (RT-PCR) detection of influenza A and B viruses, parainfluenza virus 1–4 (10), human metapneumovirus, RSV (11), adenovirus, Chlamydia spp., and Mycoplasma pneumoniae (12) was performed according to previously published protocols. HBoV primers 188F (5´-GAGCTCTGTAAGTACTATTAC-3´) and 542 R (5´-CTCTGTGTTGACTGAATACAG-3´) that target the NP-1 protein gene and produce a 354-bp amplicon were used as described and modified by Allander et al. (8). Other potential respiratory pathogens such as rhinoviruses and coronaviruses were not investigated because they are associated primarily with upper respiratory infections.

A total of 326 children were enrolled in the study, but sufficient nucleic acid was extractable from 312 NPAs for detection of each potential respiratory pathogen. For the remainder, the volume of NPA was too small for extraction of both DNA and RNA Of these, 57 (18.3%) children were infected with HBoV (Table). The median age of HBoV-infected patients was 8 months and 29 (51%) were male, compared with a median age of 6 months and 156 (61%) male patients in the HBoV-negative patients (p>0.2). HBoV was detected in 30 (21.7%) of 138 children with severe ARI and in 27 (15.5%) of 174 children with mild-to-moderate ARI (p>0.2). However, only HBoV was detected in 13 (48%) of the 27 patients with mild-to-moderate ARI and with adenovirus (10 patients), RSV (2 patients) Chlamydia spp. (1 patient), and RSV and adenovirus (1 patient) in the 14 remaining patients with mild-to-moderate disease. In patients with severe ARI in whom HBoV was detected, it was the only pathogen in 3 (10%) patients. In the remaining 27 cases, it was found as a mixed infection with RSV (9 patients), RSV and adenovirus (8 patients), RSV and Chlamydia spp. (2 patients), RSV and influenza A virus (1 patient), HMPV and Chlamydia spp. (1 patient) and adenovirus (6 patients). The median age was 3.5 months for those infected only with HBoV and 10 months (p = 0.012) for those co-infected with HBoV and other potential pathogens.

Direct sequencing (Lark Technologies, Essex, UK) was undertaken for 14 (25%) of the amplicons. Four amplicons had the same sequence as the original Swedish strain. Five variants were detected. One cluster (DNA Data Bank of Japan accession no. AB243566 available from contained 5 strains with mutations at codons 21 (R→K) and 59 (S→N). Another cluster (AB 243570) contained 2 strains with 1 mutation at codon 79 (S→N). Three other variants were detected with changes at codons 26 (R→K), 29 (Q→R), and 59 (S→N) (AB243568), codons 21 (R→K) and 79 (S→N) (AB243569), and codon 42 (R→Q) (AB243567), respectively. No connections were found between patients with different variants except for AB243570, in which 2 strains were isolated from 2 children at the same orphanage in Amman who came to the hospital on the same day. One had mild-to moderate-disease, and the other had severe disease.


We detected HBoV in 57 (18.3%) of 312 children with ARI severe enough to require hospital admission. HBoV was detected in 30 (21.7%) of those admitted who were classified according to WHO criteria as having severe ARI. Other reported prevalences are 24 (3%) of 806 pediatric samples in Sweden (8), 18 (5.6%) of 324 children <3 years of age in Australia (6), and 18 (5.7%) of 318 children <3 years of age in Japan (13). These data support an association between the virus and ARI.

As in the Australian study (6), mixed infections were common. In the Australian study, HBoV was detected with other potential respiratory pathogens in ≈56% of patients. In our study, the prevalence (72%) of mixed infection was even higher, occurring most often as a co-infection with RSV. HBoV was found as sole pathogen in 2% of cases of severe ARI and in 7.5% of mild-to-moderate ARI.

This study was conducted during the peak period of ARI in Jordan, and the prevalence of detection of HBoV ranged from 12.9% in March to 37% in April. However, larger cross-sectional studies and longitudinal studies of HBoV-infected children are needed to determine whether HBoV causes ARI, its effect on children, and its seasonality. In addition, HBoV, similar to some adenoviruses (14) and other human parvoviruses, may show persistent shedding after an initial acute infection.

Finally, we have also obtained evidence for variations in the HBoV NP-1 gene. In addition to the original Swedish strain, we found 5 variants with point mutations in the gene causing amino acid substitution in the deduced protein. What role this might play in HBoV pathogenesis and whether other genes encoding nonstructural protein 1 (NS-1) and virion proteins 1/2 (VP1/2) show similar variability are unclear. However, 2 CPV-1 strains showed 96.5%, 92.5%, and 97.5% homology in their NS-1-, NP-1-, and VP1/2-deduced proteins (15).

Dr Kaplan is a consultant medical microbiologist at the King Hussein Medical Centre in Amman, Jordan. His research interest is childhood acute respiratory tract infections.



  1. Murray  CJL, Lopez  AD. Mortality by cause for eight regions of the world: global burden of disease. Lancet. 1997;349:126976. DOIPubMedGoogle Scholar
  2. Bryce  J, Boschi-Pinto  C, Shibua  K. Black RE and the WHO Child Health Epidemiology Reference Group. WHO estimation of the causes of death in children. Lancet. 2005;365:114752. DOIPubMedGoogle Scholar
  3. Shay  DK, Holman  RC, Roosevelt  GE, Clarke  MJ, Anderson  LJ. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979–1997. J Infect Dis. 2001;183:1622. DOIPubMedGoogle Scholar
  4. van den Hoogen  BG, de Jong  JC, Groen  J, Kuiken  T, de Groot  R, Fouchier  RA, A newly discovered human pneumonovirus isolated from young children with respiratory tract disease. Nat Med. 2001;7:71924. DOIPubMedGoogle Scholar
  5. Peiris  JS, Chu  CM, Cheng  VC, Chan  KS, Hung  IF, Poon  LL, Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:176772. DOIPubMedGoogle Scholar
  6. Sloots  TP, McErlean  P, Speicher  DJ, Arden  KE, Nissen  MD, Mackay  IM. Evidence of human coronavirus HKU1 and human bocavirus in Australian children. J Clin Virol. 2005;35:99102. DOIPubMedGoogle Scholar
  7. van der Hoek  L, Pyrc  K, Jebbink  MF, Vermeulen-Oost  W, Berkhoot  RJ, Wolthers  KC, Identification of a new human coronavirus. Nat Med. 2004;10:36871. DOIPubMedGoogle Scholar
  8. Allander  T, Tammi  MT, Eriksson  MB, Bjerkner  A, Tiveljung-Tindell  A, Andersson  B. Cloning of a human parvovirus by screening of respiratory tract samples. Proc Natl Acad Sci U S A. 2005;102:128916. DOIPubMedGoogle Scholar
  9. Pio  A. Standard case management of pneumonia in children in developing countries: the cornerstone of the acute respiratory infection programme. Bull World Health Organ. 2003;81:298300.PubMedGoogle Scholar
  10. Templeton  KE, Scheltinga  SA, Beersma  MF, Kroes  AC, Claas  AC. Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza A and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1, 2, 3 and 4. J Clin Microbiol. 2004;42:15649. DOIPubMedGoogle Scholar
  11. Greensill  J, McNamara  PS, Dove  W, Flanagan  B, Smyth  RL, Hart  CA. Human metapneumovirus in severe respiratory syncytial virus bronchiolitis. Emerg Infect Dis. 2003;9:3725.PubMedGoogle Scholar
  12. Couroucli  XI, Welty  SE, Ramsay  PC, Wearden  ME, Fuentes-Gareia  FJ, Ni  J, Detection of microorganisms in the tracheal aspirates of preterm infants by polymerase chain reaction: association of adenovirus with bronchopulmonary dysplasia. Pediatr Res. 2000;47:22532. DOIPubMedGoogle Scholar
  13. Ma  X, Endo  R, Ishiguro  N, Ebihara  T, Ishiko  H, Arigo  T, Detection of human bocavirus in Japanese children with lower respiratory tract infections. J Clin Microbiol. 2006;44:11324. DOIPubMedGoogle Scholar
  14. Kaye  SB, Lloyd  M, Williams  H, Yuen  C, Scott  JA, O'Donnell  N, Evidence for persistence of adenovirus in the tear film a decade following conjunctivitis. J Med Virol. 2005;77:22731. DOIPubMedGoogle Scholar
  15. Ohshima  T, Kishi  M, Mochizuki  M. Sequence analysis of an Asian isolate of minute virus of canines (canine parvovirus type 1). Virus Genes. 2004;29:2916. DOIPubMedGoogle Scholar




Cite This Article

DOI: 10.3201/eid1209.060417

Table of Contents – Volume 12, Number 9—September 2006


Please use the form below to submit correspondence to the authors or contact them at the following address:

C. Anthony Hart, Department of Medical Microbiology, University of Liverpool, Duncan Bldg, Daulby St, Liverpool L69 3GA, UK

Send To

10000 character(s) remaining.


Page created: November 18, 2011
Page updated: November 18, 2011
Page reviewed: November 18, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.